Standard GLP-1 titration schedules come from clinical trials, and clinical trials are designed to demonstrate maximum effect within a fixed window. That is a reasonable goal for a trial. It is a strange goal for your life.
The escalation schedule on the label moves you upward every four weeks regardless of whether you needed the increase. If the previous dose was already working, you get the side effects of the higher one without a corresponding benefit.
The dose-response curve isn't linear
Appetite suppression and gastrointestinal side effects do not rise together in a neat line. For many people, most of the appetite effect arrives in the first two dose levels, while nausea, fatigue and constipation continue climbing well past that point.
That gap is the entire argument for microdosing. If you capture eighty percent of the appetite benefit at thirty percent of the dose, and the remaining twenty percent costs you your mornings, the arithmetic favors staying low.
What this looks like in practice
- Start at roughly a quarter to a half of the labeled starting dose.
- Hold for at least four weeks and track hunger, not just weight.
- If food noise has quieted and the scale is moving, stay put.
- If the effect fades after several weeks, increase by the smallest available increment.
- Repeat. Most people find their ceiling well below the labeled target dose.
The trade-off you are accepting
Microdosing is slower. If you compare a microdose protocol against full-dose titration at the six-month mark, full dose usually wins on total pounds lost. We think that comparison is the wrong one, because it silently excludes everyone who quit.
Discontinuation rates in real-world GLP-1 use are high, and side effects are the leading reported reason. A protocol you stay on for a year beats a protocol you abandon in month two, even if the second one has a steeper early slope.
“The best dose is not the highest one you can tolerate. It is the lowest one that still does the job.”
Who this is not for
If you have a large amount of weight to lose on a medical timeline — before a surgery, for instance — a slower protocol may not serve you. Microdosing is a tolerability strategy, not a universally superior one, and your clinician should tell you when it's the wrong tool.